Molina closes $60M acquisition of Cigna’s Medicaid contracts in Texas
Molina is known for being acquisitive, but has been on a recent tear as it looks to capitalize on tailwinds in the Medicaid program.
Medtechs brace for hit as hospitals warn of omicron impact on surgeries
Healthcare staff shortages and rising COVID-19 admissions are forcing hospitals to cancel elective surgeries and postpone diagnostic and imaging procedures.
Nurses at Massachusetts Tenet hospital ratify contract, ending 9-month strike
The deal includes some staffing improvements that were top priorities for nurses, including limits on how many patients can be assigned in certain hospital units, along with wage increases, the union said.
UnitedHealthcare permanently shelves controversial ER coverage changes following confusion
Following concerns from hospitals regarding an apparent change to its ER coverage policy, the payer clarified no changes were made — or will be made — to how it approves or denies its members’ emergency claims.
HCA buys urgent care chain in Florida
HCA continues to double down on the Florida market where it has invested $3 billion over the last three years.
Roche, Siemens at-home tests get FDA EUAs as US faces COVID-19 testing shortage
The agency granted emergency use authorizations to both companies’ over-the-counter diagnostics under a new accelerated review program. However, it may take months for them to scale up production.
Supreme Court sets Jan. 7 hearing on vaccine mandate rules
The justices will hear arguments on the requirement that healthcare workers must be fully vaccinated, amid a flurry of legal challenges.
Tenet completes $1B surgery center acquisition
This is the second billion-dollar deal with SurgCenter Development in as many years as Tenet continues building out its surgery center footprint, a key component of its long-term strategy.
J&J device chief on company split, omicron surge, robotic surgery
Ashley McEvoy is confident that 2022 will not be as bad as the first or second year of the COVID-19 pandemic, even as the omicron variant drives cases up, but adds that “we’re not out of the woods yet.”
COVID-19 pill from Pfizer authorized by FDA in major pandemic milestone
Paxlovid is the first oral treatment for COVID-19, a potentially valuable new tool as the fast-spreading omicron variant fuels a sharp surge in cases across the U.S.